Abstract - Recent FDA cleared/approved devices and biologics as well as current clinical trials in these types of products which promised improved vision by neurorecovery or at least slowing of the vision loss progression with neuroprotection including: 1) Spark Therapeutics LUXTURNA gene therapy; and 2) Okuvision OkuStim Electrical Stimulation Therapy. In addition, retinal and cortical prosthetics have promised restored vision by substituting mechanisms in the visual system. This presentation will provide a review of the actual results of these types of products and the challenges that
Have You Heard About the Latest Products for people who have vision loss, FDA Cleared or Not?
Abstract - Dr. Ron Schuchard will review the recent research and development for products that are marketed for treatment of vision loss. This review draws from his experiences as a vision rehabilitation researcher and as a FDA senior staff member. Attendees will also be encouraged to ask about treatments for vision loss that are of interest to them.